AKT1 and neoplasm: Collectively, our findings indicated that CAF-derived PAI-1 induces EndoMT in LECs by activating the LRP1/ERK1/2/AKT pathway, which in turn drives abnormal lymphangiogenesis, thereby facilitating tumour lymphoinvasion and CSCC progression.